Details of OGTR monitoring and compliance activities during the quarter ended 30 June 2025.
This document provides guidance to applicants on what documents can be provided to support their licence applications or variations
There has been confusion regarding the baits used in the National Fire Ant Eradication Program. The following statement addresses this confusion.
This Communique covers matters considered at the 21st meeting of the Gene Technology Ethics and Community Consultative Committee (25 February 2025).
Trial of genetically modified vaccines against Ross River virus infection in horses
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2024-25.
Clinical trial of a genetically modified Escherichia coli for the treatment of ulcerative colitis
This issue focuses on 50 years since The Asilomar Conference.
GTECCC’s story-telling case studies for communicating on gene technology.